oral glp-1 agonist approved Danuglipron: An GLP-1R Competing with Peptide Injectables for Diabetes and Obesity Lilly is now pharma's top

The primary end point (a composite of death from cardiovascular causes, non-fatal myocardial infarction, or non-fatal stroke) occurred in 305 patients with alogliptin (11.3%) and in 316 patients with placebo (11.8%), which was not significantly different

Its always best to draw each dose from the glass vial immediately before use

While 64% of infants receive acetaminophen after vaccination, newborns have severely underdeveloped detoxification systems

Advances in experimental medicine and biology, 1131, 215242

Fox Foundation for Parkinsons Research and the Parkinsons Foundation

This mimics the way the body naturally transports certain nutrients, making it a more intuitive way for our cells to receive support